As of August 28, 2026, Neumora Therapeutics, Inc. (NMRA) has a DilutionWatch DilutionScore of 47/100, rated MEDIUM dilution risk. Neumora Therapeutics, Inc. has a market capitalization of $342.78M, 187.90M shares outstanding, 117 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
⛅
Watch
Minor dilution signals detected
model est. 17%
🔄 Reverse Split
model est. 25%
• 52-week low $0.69 has breached $1
• 10 months cash with weak price
💰 Capital Raise
model 15%
• Under 12 months cash (10mo)
Market Data
Market Cap$342.78M
Shares Outstanding187.90M
Float104.83M
Cash$159.29M
Debt$112.91M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 38.0% shares (2026Q1 vs prior)
117 institutional holders · 87.49M shares
#1
PERCEPTIVE ADVISORS LLC
10.21M shares
#2
Siren, L.L.C.
8.50M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
7.78M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest7.62M
Days to Cover11.0
% of Float7.3%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2025-12-31
Form 4
INSIDER TRANSACTION
2026-08-21
Form 4
INSIDER TRANSACTION
2026-08-21
Form 4
INSIDER TRANSACTION
2026-08-21
Form 4
INSIDER TRANSACTION
2026-08-21
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual NMRA Dilution Snapshot
Neumora Therapeutics, Inc. (NMRA) has a DilutionScore of 47/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for NMRA: Form 4 on 2026-08-21; Form 4 on 2026-08-21; Form 4 on 2026-08-21.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track NMRA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NMRA — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for NMRA
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.